Evidence map›Paper›PMID 34071596›Full record

ReviewCells2021

Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State-New Directions in Anti-Aging Regenerative Therapies.

Klaudia Maar, Roland Hetenyi, Szabolcs Maar, Gabor Faskerti, Daniel Hanna, Balint Lippai, Aniko Takatsy, Ildiko Bock-Marquette

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. [Thymosin β4 inhibits pyroptosis in BV2 microglial cells: a mechanistic studyZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Article
  2. Article
  3. Article
  4. The role ofJournal of gastrointestinal oncology · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Klaudia MaarDepartment of Biochemistry and Medical Chemistry, Medical School, University of Pecs, Szigeti Street 12., H-7624 Pecs, Hungary.
Roland HetenyiDepartment of Biochemistry and Medical Chemistry, Medical School, University of Pecs, Szigeti Street 12., H-7624 Pecs, Hungary.
Szabolcs MaarDepartment of Biochemistry and Medical Chemistry, Medical School, University of Pecs, Szigeti Street 12., H-7624 Pecs, Hungary.
Gabor FaskertiDepartment of Biochemistry and Medical Chemistry, Medical School, University of Pecs, Szigeti Street 12., H-7624 Pecs, Hungary.
Daniel HannaDepartment of Biochemistry and Medical Chemistry, Medical School, University of Pecs, Szigeti Street 12., H-7624 Pecs, Hungary.
Balint LippaiSzentagothai Research Centre, Research Group of Regenerative Science, Sport and Medicine, University of Pecs, Ifjusag Street 20. C301, H-7624 Pecs, Hungary.
Aniko TakatsyDepartment of Biochemistry and Medical Chemistry, Medical School, University of Pecs, Szigeti Street 12., H-7624 Pecs, Hungary.
Ildiko Bock-MarquetteDepartment of Biochemistry and Medical Chemistry, Medical School, University of Pecs, Szigeti Street 12., H-7624 Pecs, Hungary.
University of Pecs · HU

Funding

National Research, Development and Innovation Office of Hungary GINOP-2.3.2-15-2016-00047National Research, Development and Innovation Office of Hungary OTKA-K108550The National Research, Development and Innovation Office of Hungary 2020-4.1.1-TKP2020
6 · The paper itself

Abstract

Our dream of defeating the processes of aging has occupied the curious and has challenged scientists globally for hundreds of years. The history is long, and sadly, the solution is still elusive. Our endeavors to reverse the magnitude of damaging cellular and molecular alterations resulted in only a few, yet significant advancements. Furthermore, as our lifespan increases, physicians are facing more mind-bending questions in their routine practice than ever before. Although the ultimate goal is to successfully treat the body as a whole, steps towards regenerating individual organs are even considered significant. As our initial approach to enhance the endogenous restorative capacity by delivering exogenous progenitor cells appears limited, we propose, utilizing small molecules critical during embryonic development may prove to be a powerful tool to increase regeneration and to reverse the processes associated with aging. In this review, we introduce Thymosin beta-4, a 43aa secreted peptide fulfilling our hopes and capable of numerous regenerative achievements via systemic administration in the heart. Observing the broad capacity of this small, secreted peptide, we believe it is not the only molecule which nature conceals to our benefit. Hence, the discovery and postnatal administration of developmentally relevant agents along with other approaches may result in reversing the aging process.

Indexed as

AgingAnimalsEmbryonic DevelopmentHumansRegenerationThymosinThymosin beta(4)ThymosinThymosin beta(4)agingembryonic developmentheart regenerationthymosin beta-4

Identifiers

PMID34071596
PMCPMC8228050
OpenAlexW3164004512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.